The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce it has completed initial designs for a commercial hemp root oil production facility, and sourced and ordered key equipment for its proprietary extraction technology.
After reviewing the data from its hemp root oil production to date, Yield Growth designed a state-of-the-art system to enhance the traditional Ayurvedic methods of extraction that produce a consistent, high-quality product.
In Ayurveda, roots are considered the most healing part of the plant, and have been used in medicine for over 5,000 years. While the ancient extraction methods retain the integrity of the medicinal properties of the plant, they are labour-intensive and time consuming. Conversely, the available modern techniques often dilute the health benefits of the plant and its derivatives. Through innovation and proprietary technologies, Yield Growth has developed a new, scalable extraction method that retains Ayurvedic principles and preserves the beneficial properties of the plant. The result: an efficient and effective process that yields high-quality hemp root oil.
Yield Growth will continue to innovate and conduct further research on creating cannabidiol from industrial hemp over the next few quarters. The versatility of the new equipment allows further refinement to the process of extracting cannabinoids from industrial hemp that are exempt from the Cannabis Act. Yield Growth will continue to develop unique products through its patent-pending extraction technology—and enhance the bioavailability of botanicals through the skin.
Extraction equipment will arrive within weeks, allowing for the production and testing of sample batches of hemp root oil using the enhanced design. Yield Growth anticipates the new commercial hemp root oil extraction facility will be fully operational by late 2019.
Yield Growth has engaged Winning Media to develop market awareness for potential investors through digital marketing. Yield Growth also engages CFN Media, Stockhouse Publishing, Market IQ Media, and the Globe & Mail for digital advertising and sponsored content related to corporate brand awareness.
About The Yield Growth Corp.
The Yield Growth Corp. is disrupting the $4.2 trillion-dollar global wellness market with hemp and cannabis-infused products that connect ancient healing with modern science. It is a vertically-integrated asset company with the leadership, financial position, and science-backed formulas to capitalize on the cannabis revolution. The Yield Growth management team has deep experience with relevant global brands including Johnson & Johnson, Procter & Gamble, M·A·C Cosmetics, Skechers, Best Buy, Aritzia, Coca-Cola, and Pepsi Corporation. Yield Growth serves mainstream, luxury consumers who demand sophisticated wellness solutions. Its flagship consumer brand, Urban Juve, has registered 35 products with Health Canada. Key ingredients in these products include Cannabis Sativa hemp seed oil and hemp root oil created using Urban June’s proprietary, patent-pending extraction technology. Urban Juve has also filed 11 provisional patents in the United States. Through its subsidiaries, Yield Growth is commercializing over 70 wellness products and has multiple revenue streams including licensing, incubation services and product sales.
Investor Relations Contacts:
Penny Green, President & CEO
Kristina Pillon, Investor Relations
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve, UJ Topicals, UJ Beverages and UJ Edibles products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/